This inventor holds 1 USPTO granted patent and 3 published patent applications and 1 EPO patent. Top assignee: Dompé Farmaceutici S.p.a.. Active years: 2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2024
Title: Scott Coleman: Innovator in Triglyceride Otic Formulations
Introduction
Scott Coleman is a notable inventor based in San Diego, CA. He has made significant contributions to the field of otic formulations, particularly through his innovative work on triglyceride-based compositions. His research focuses on the treatment of otic diseases and conditions, showcasing his commitment to advancing medical science.
Latest Patents
Scott Coleman holds a patent for "Triglyceride otic formulations and uses thereof." This patent discloses triglyceride-based formulations, compositions, and methods for treating various otic diseases. The formulations are derived from long-chain triglycerides, allowing for the effective delivery of therapeutic agents to the outer, middle, and inner ear.
Career Highlights
Throughout his career, Scott has demonstrated a strong dedication to research and development in the pharmaceutical industry. He is currently associated with Dompé Farmaceutici S.p.a., where he continues to innovate and contribute to the field of otic health.
Collaborations
Scott Coleman has collaborated with esteemed colleagues, including Robert Savel and Zhanpeng Zhang. These partnerships have further enhanced his research and development efforts, leading to advancements in otic formulations.
Conclusion
Scott Coleman's work in triglyceride otic formulations represents a significant advancement in the treatment of ear diseases. His innovative approach and dedication to research continue to impact the field positively.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile